𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care

✍ Scribed by H. H. Hirsch; H. Drechsler; A. Holbro; F. Hamy; P. Sendi; K. Petrovic; T. Klimkait; M. Battegay


Book ID
106271354
Publisher
Springer
Year
2005
Tongue
English
Weight
126 KB
Volume
24
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term monitoring of genotypic and ph
✍ L. Pérez-Alvarez; R. Carmona; A. Ocampo; A. Asorey; C. Miralles; S. Pérez de Cas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The aim of this study was to investigate the susceptibility to T20 and the dynamics of amino acid changes in HR1 and HR2 of gp41 of HIV-1 obtained from plasma, peripheral blood mononuclear cells (PBMC), and primary isolates (PI) in four highly antiretroviral-experienced patients. These patients rece

Evolution of genotypic and phenotypic re
✍ Eva Poveda; Berta Rodés; Jean-Louis Labernardière; José Miguel Benito; Carlos To 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Four heavily antiretroviral‐experienced HIV‐infected patients had significant plasma HIV‐RNA reductions (>1 log) after beginning an Enfuvirtide (ENF)‐based rescue regimen. However, all had viral rebound shortly thereafter, sustaining high levels of plasma viremia over 80 weeks. These pa

Longitudinal use of phenotypic resistanc
✍ Jean Servais; Jean-Marc Plesséria; Christine Lambert; Elodie Fontaine; Isabelle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract An “in‐house” recombinant virus protease inhibitor susceptibility assay was carried out (median of 3 per patient) retrospectively in 26 patients failing HIV protease inhibitor based therapy at regular intervals to the initiation of the first protease inhibitor. Patients were treated wit

Virological and immunological effects of
✍ Jacques Izopet; Corinne Souyris; Karine Sandres-Sauné; Bénédicte Puissant; Marti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract The circulating human immunodeficiency virus type 1 (HIV‐1) population of patients in whom many prior therapy regimens have failed often undergo a shift from a drug‐resistant virus to a wild‐type virus following interruption of treatment. This study analyses the virological and immunolo